Recall D-0650-2024
Description: Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
Recall D-0650-2024 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0650-2024 |
| Event ID | 95190 |
| Distribution | Nationwide in the USA |
| Quantity | 2,490 vials |
| Recall Reason | Lack of Assurance of Sterility |
| Drug Classification | Class II |
| Drug Code Info | 20240911 |
| Recall Initiation Date | 20240822 |
| Report Date | 20240911 |
| Classification Date | 20240905 |
| Address | 619 Jeffers Cir Exton, PA 19341-2540 United States |
| Recalling Firm | ProRx LLC |
| Initial Notification | Letter |
| Similar To |